Portal de Periódicos da CAPES

Re: Propranolol Treatment for Hemangioma of Infancy: Risks and Recommendations

2010; Wiley; Volume: 27; Issue: 3 Linguagem: Inglês

10.1111/j.1525-1470.2010.01125.x

1525-1470

Susan J. Bayliss, David R. Berk, George F. Van Hare, David T. Balzer, Kelvin A. Yamada, Gregg T. Lueder, Agustina Lanoël, V. de la Fuente, Maria Cordisco,

Parvovirus B19 Infection Studies

Pediatric DermatologyVolume 27, Issue 3 p. 319-320 Re: Propranolol Treatment for Hemangioma of Infancy: Risks and Recommendations Susan J. Bayliss M.D., Susan J. Bayliss M.D. St. Louis, MissouriSearch for more papers by this authorDavid R. Berk M.D., David R. Berk M.D. St. Louis, MissouriSearch for more papers by this authorGeorge F. Van Hare M.D., George F. Van Hare M.D. St. Louis, MissouriSearch for more papers by this authorDavid Balzer M.D., David Balzer M.D. St. Louis, MissouriSearch for more papers by this authorKelvin Yamada M.D., Kelvin Yamada M.D. St. Louis, MissouriSearch for more papers by this authorGregg Lueder M.D., Gregg Lueder M.D. St. Louis, MissouriSearch for more papers by this authorAgustina Lanoel M.D., Agustina Lanoel M.D. Ciudad de Buenos Aires, Argentina e-mail: [email protected]Search for more papers by this authorVictoria De La Fuente M.D., Victoria De La Fuente M.D. Ciudad de Buenos Aires, Argentina e-mail: [email protected]Search for more papers by this authorMaria Rosa Cordisco M.D., Maria Rosa Cordisco M.D. Ciudad de Buenos Aires, Argentina e-mail: [email protected]Search for more papers by this author Susan J. Bayliss M.D., Susan J. Bayliss M.D. St. Louis, MissouriSearch for more papers by this authorDavid R. Berk M.D., David R. Berk M.D. St. Louis, MissouriSearch for more papers by this authorGeorge F. Van Hare M.D., George F. Van Hare M.D. St. Louis, MissouriSearch for more papers by this authorDavid Balzer M.D., David Balzer M.D. St. Louis, MissouriSearch for more papers by this authorKelvin Yamada M.D., Kelvin Yamada M.D. St. Louis, MissouriSearch for more papers by this authorGregg Lueder M.D., Gregg Lueder M.D. St. Louis, MissouriSearch for more papers by this authorAgustina Lanoel M.D., Agustina Lanoel M.D. Ciudad de Buenos Aires, Argentina e-mail: [email protected]Search for more papers by this authorVictoria De La Fuente M.D., Victoria De La Fuente M.D. Ciudad de Buenos Aires, Argentina e-mail: [email protected]Search for more papers by this authorMaria Rosa Cordisco M.D., Maria Rosa Cordisco M.D. Ciudad de Buenos Aires, Argentina e-mail: [email protected]Search for more papers by this author First published: 25 May 2010 https://doi.org/10.1111/j.1525-1470.2010.01125.xCitations: 14Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1 Lawley LP, Siegfried E, Todd JL. Propranolol treatment for hemangioma of infancy: risks and recommendations. Pediatr Dermatol 2009; 26: 610–614. 10.1111/j.1525-1470.2009.00975.x PubMedWeb of Science®Google Scholar 2 Gillette P, Garson A, Eterovic E et al. Oral propranolol treatment in infants and children. J Pediatr 1978; 92: 141–144. 10.1016/S0022-3476(78)80096-1 CASPubMedWeb of Science®Google Scholar 3 Ostman-Smith I, Wettrell G, Riesenfeld T. A cohort study of childhood hypertrophic cardiomyopathy: improved survival following high-dose beta-adrenoceptor antagonist treatment. J Am Coll Cardiol 1999; 34: 1813–1822. 10.1016/S0735-1097(99)00421-0 CASPubMedWeb of Science®Google Scholar 4 Sans V, Dumas de la Roque E, Berge J et al. Propranolol for severe infantile hemangiomas: follow-up report. Pediatrics 2009; Aug 10 [Epub ahead of print]. 10.1542/peds.2008-3458 PubMedWeb of Science®Google Scholar 5 Löffler H, Kosel C, Cremer H et al. Propranolol therapy to treat problematic hemangiomas: a new standard therapy makes its debut. Hautarzt 2009; 60: 1013–1016. 10.1007/s00105-009-1856-4 CASPubMedWeb of Science®Google Scholar 6 Buckmiller LM. Propranolol treatment for infantile hemangiomas. Curr Opin Otolaryngol Head Neck Surg 2009; 17: 458–459. 10.1097/MOO.0b013e328332a4eb PubMedWeb of Science®Google Scholar 7 Jephson CG, Manunza F, Syed S et al. Successful treatment of isolated subglottic haemangioma with propranolol alone. Int J Pediatr Otorhinolaryngol 2009; 73: 1821–1823. 10.1016/j.ijporl.2009.08.020 PubMedWeb of Science®Google Scholar 8 Wachter K. More data add to propranolol buzz. Skin Allergy News 2009; 40:1–9. 10.1016/S0037-6337(09)70171-8 Google Scholar 9 Powell J. Propranolol in the treatment of infantile hemangioma: clinical observations in 20 consecutive patients from a vascular anomalies clinic. Paper presented at: Canadian Dermatology Association 84th Annual Conference; July 3, 2009; Vancouver, BC. Google Scholar 10 Drolet BA, Dohil M, Golomb MR et al. Early stroke and cerebral vasculopathy in children with facial hemangiomas and PHACE association. Pediatrics 2006; 117: 959–964. 10.1542/peds.2005-1683 PubMedWeb of Science®Google Scholar Citing Literature Volume27, Issue3May/June 2010Pages 319-320 ReferencesRelatedInformation